Clinical significance of mutations in dihydropteroate synthase in Pneumocystis jirovecii pneumonia among non-HIV-infected patients-Reference-Cited by-同舟云学术

Clinical significance of mutations in dihydropteroate synthase in Pneumocystis jirovecii pneumonia among non-HIV-infected patients

Published:2024-01 Issue:1 Volume:63 Page:107019
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Liao Ting-Yu^ORCID,Huang Yu-Tsung,Lee Tai-Fen,Hsueh Po-Ren,Yu Chong-Jen,Chien Jung-Yien^ORCID

Funder

Ministry of Science and Technology

Ministry of Science and Technology, Taiwan

National Taiwan University Hospital

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference31 articles.

1. Evaluation of a new commercial real-time PCR assay for diagnosis of Pneumocystis jirovecii pneumonia and identification of dihydropteroate synthase (DHPS) mutations;Montesinos;Diagn Microbiol Infect Dis,2017

2. In search of clinical factors that predict risk for Pneumocystis jirovecii pneumonia in patients without HIV/AIDS;Limper;Am J Respir Crit Care Med,2018

3. Pneumocystis jirovecii pneumonia in patients with or without AIDS, France;Roux;Emerg Infect Dis,2014

4. A model to predict in-hospital mortality in HIV/AIDS patients with pneumocystis pneumonia in China: the clinical practice in real world;Wu;Biomed Res Int,2019

5. Colonization by Pneumocystis jirovecii and its role in disease;Morris;Clin Microbiol Rev,2012

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress on nonculture based diagnostic tests for invasive mould infection;Current Opinion in Infectious Diseases;2024-09-16